| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $860K | -15.3% | -1.3% |
| Cost of Revenue | $461K | -2.7% | -3.8% |
| R&D Expense | $3.1M | +0.7% | +21.8% |
| SG&A Expense | $4.1M | -1.0% | +4.4% |
| Operating Income | -$8.1M | +0.4% | -10.5% |
| Pre-tax Income | -$3.7M | +50.0% | +47.3% |
| Income Tax | $0 |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $27.4M | +35.8% | +28.3% |
| Short-term Investments | $29.8M | -30.0% | — |
| Accounts Receivable | $326K | +37.6% | -47.2% |
| Inventory | $76K | +0.0% | — |
| Current Assets | $60.5M | -8.1% | +145.0% |
| Total Assets | $72.9M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$19.1M | — | — |
| Capital Expenditures | $477K | — | — |
| Investing Cash Flow | -$20.3M | — | — |
| Financing Cash Flow | $35.6M | — | — |
| Free Cash Flow | -$19.6M | — | — |
| — |
| -100.0% |
| Net Income | -$3.7M | +50.0% | +47.3% |
| EPS (Basic) | -$0.09 | +55.0% | +66.7% |
| EPS (Diluted) | -$0.09 | +55.0% | +66.7% |
| -6.9% |
| +88.3% |
| Current Liabilities | $4.5M | +16.1% | -9.3% |
| Total Liabilities | $21.1M | -13.9% | +37.6% |
| Stockholders' Equity | $51.8M | -3.7% | +121.4% |